Skip to main content
Equibles

Invesco Ltd.

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 914208 Atlanta, GA
Back to RYTM Full portfolio

Position in RYTM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$60,319,376
+$28,635,685 QoQ
Shares Held
543,271
+49.1% QoQ
Ownership
0.789%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in RYTM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. RYTM ranks #28 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in RYTM

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $60,319,376 543,271
2026-03-31 $31,683,691 364,306
2025-12-31 $31,164,694 291,150
2025-09-30 $14,497,617 143,555
2025-06-30 $4,355,305 68,924
2025-03-31 $13,872,947 261,902
2024-12-31 $16,953,315 302,846
2024-09-30 $13,852,805 264,417
2024-06-30 $11,361,300 276,700
2024-03-31 $3,821,920 88,205
2023-12-31 $6,239,553 135,731
2023-09-30 $650,472 28,374
2023-06-30 $466,270 28,276
2022-12-31 $9,734,029 334,273
2022-03-31 $190,159 16,507
2021-12-31 $241,993 24,248
2021-09-30 $356,968 27,333
2021-06-30 $495,529 25,308
2021-03-31 $365,992 17,207
2020-12-31 $434,414 14,612
2020-09-30 $215,919 9,964
2020-06-30 $225,988 10,134
2020-03-31 $169,352 11,127